Published 💜 @JRheumatology
Interleukin 6 Levels and Disease Activity in Takayasu Arteritis: A Systematic Review With Meta-analysis https://t.co/AhrclAaR8Z
“Although it may be difficult, or even impossible in some cases, to distinguish between axial PsA and primary axSpA due to overlapping features, axial PsA can have distinct clinical presentations, genetic factors, radiographic characteristics, and possibly response to treatment.”
May as well join the fun: TYPES OF [X] PAPERS - RHEUM-EDITION!
Special thanks to @BenMazer for this article https://t.co/puC4PMCfc5
And to this website: https://t.co/8B1AdtVBxz
And sorry if someone already did this! Had not seen yet for rheum but wouldn't be surprised ;)
Management of #RheumatoidVasculitis remains undefined, mainly relying on high doses of corticosteroids and cyclophosphamide.
📌A new systematic review showed that RTX and anti-TNFα can be beneficial in treating this complication of #rheumatoidarthritis
👉https://t.co/UjcNCXfceC
We are proud of our publication in Clinical Rheumatology about biological therapy in rheumatoid vasculitis. Check this out: #vascultis#rheumatoidarthritis
https://t.co/h3Y3IPuYr7
For new patients with Behcets limited to mucosal ulcers without system symptoms , does anyone screen for vascular or neurologic disease with imaging. I can’t find any literature recommendations for this.